The use of the CD45, Foxp3, and CD25 markers has allowed both the frequency and the function of three distinct Treg subsets in the circulation of HNSCC patients with tumors of varying stage and nodal status to be determined. The gene discussed is PTPRC; the disease is head and neck squamous cell carcinoma.